Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AA, abnormal, actor, Adicet, Affimed, AgreementSM, Ahead, aid, aka, alleviated, alloreactivity, AlloVir, ambition, AnaptysBio, anti, array, Assoc, ATM, azacitidine, backbone, background, ban, Basel, baseline, Bedrijfsrevisoren, benchmark, benchmarking, bespoke, Beta, biomarker, Black, blunt, Brexit, Britain, calcium, CH, chairmanship, Chamber, checkpoint, clawback, clear, CMC, colon, commandeered, Commerce, compassionate, concomitantly, convey, crucial, customarily, cytochrome, decitabine, deep, depth, devaluation, diverge, diversified, Dominic, doubt, downregulate, downregulation, drew, durable, dynamic, economy, electorate, element, Elmer, emphasized, Eshhar, Eurocell, explanatory, exploded, exploding, extracellular, EY, Feb, Fellow, fifty, fill, fine, firmly, Firstly, foot, Fortune, fragmenting, freedom, freely, frozen, futility, Gastrointestinal, genome, GlaxoSMith, globe, GmbH, gold, Great, Hague, haplotype, HLA, Hofstra, ICFR, ill, immunicy, immunomodulatory, Immunopharma, immunostimulatory, immunosuppressive, induction, insignificantly, invisible, Irish, irradiated, Juno, jurisprudence, Jurkat, KEYTRUDA, kidney, Kim, Kline, KNL, KPMG, Kuur, leaving, leeway, legacy, leukocyte, leveraging, Lincoln, Lisbon, lodging, LPC, manipulation, Marina, marker, maximize, McKinsey, Medigene, Medivation, Mel, MHRA, microsatellite, mitogenic, MMRF, modular, monthly, mOS, mRNA, MSD, MSS, multiplex, multiplexed, multiplexing, naamloze, nascent, Northern, Nouscom, NSG, obliterating, onboard, ORIC, page, pair, Park, Parkinson, passion, Paterson, pembrolizumab, PerkinElmer, pertaining, phosphoinositide, pioneer, pioneering, Piscitelli, plasma, plug, pMMR, pragmatism, premise, prepaid, Prof, proficient, Programme, Promega, proteosome, pursuit, quickly, rebranded, rebranding, rectum, reintroduced, Repare, repertoire, resist, robust, roughly, Sana, SCC, seamlessly, setback, seventeen, Shield, silence, silent, slight, SMART, SME, SQZ, staggered, steadily, stored, striking, strongly, Symposium, Tarceva, technique, thereon, thirty, TME, tradename, transduction, transferrable, transposition, truncated, truncation, Ts, tuning, Udier, underpin, undetected, unqualified, unresponsive, vacant, Versant, vigorously, Viracta, wake, wave, Webinar, white, worsen, XTANDI, Yale, Zelig, zone
Removed:
accelerator, activate, activated, adaptor, ade, anaamloze, andPromega, apro, asAssociation, ASH, attainment, attest, Avenue, banked, Beauty, billion, bioactivity, bladder, breast, Bryan, cardio, ceasing, charity, Christian, collaborator, collecting, consulted, contrasted, correction, costimulatory, CRC, cri, crossed, cytotoxic, DAP, deadliest, destroy, destroyed, detection, died, diseased, divesting, domain, elimination, emerged, emerging, encode, England, enrolment, escalation, evade, exceeded, extrapolation, FileNo, filer, fluctuated, formation, fueled, gamma, Garnier, gastric, gathered, Genentech, Gleevec, golden, graft, grafted, Herceptin, hired, Homsy, HSCT, immunized, impressive, inAssoc, includinginter, incomplete, induced, infected, infinite, inflammation, Inhibiting, injecting, intracellular, inventor, irrevocably, isolate, Japanese, Johnson, Jumpstart, kill, killing, Korea, Laguna, leader, LSS, lung, lymphoblastic, malfunctioning, mediated, Michigan, micro, minimal, modulate, monotherapy, mouse, multinational, native, naturally, NDA, neoadjuvant, nonbinding, ovarian, overcoming, Oxley, pancreatic, parachute, paradigm, perspective, PhD, Poor, proceeded, proliferate, rating, regorafinib, relied, rented, resection, resignation, satellite, seasonality, secretion, SEER, Sentman, SHRINK, stimulatory, stressed, sublicensed, sublicensing, successive, suppressing, suppressive, surgical, surviving, Taiwan, thrive, tightly, till, ULBP, undergone, unrelated, vast, version, viability, volatile, window, withdrew, wound, yielded, Zeta
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 1.1 EX-1.1
- 4.1 EX-4.1
- 4.2 EX-4.2
- 4.3 EX-4.3
- 4.16 EX-4.16
- 4.19 EX-4.19
- 4.20 EX-4.20
- 4.21 EX-4.21
- 4.22 EX-4.22
- 4.24 EX-4.24
- 4.25 EX-4.25
- 4.26 EX-4.26
- 4.27 EX-4.27
- 4.28 EX-4.28
- 8.1 EX-8.1
- 12.1 EX-12.1
- 13.1 EX-13.1
- 15.1 EX-15.1
- 15.2 EX-15.2
- Download Excel data file
- View Excel data file
CLYYF similar filings
Filing view
External links
Exhibit 15.2
Consent of independent registered public accounting firm
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form F-3 No. 333-248464) of Celyad Oncology SA, and |
(2) | Registration Statement (Form S-8 No. 333-220737) pertaining to the Warrants plan 2017 |
of our reports dated March 24, 2021, with respect to the consolidated financial statements of Celyad Oncology SA and the effectiveness of internal control over financial reporting of Celyad Oncology SA included in this Annual Report (Form 20-F) of Celyad Oncolgoy SA for the year ended December 31, 2020.
/s/ EY Réviseurs d’Entreprises / EY Bedrijfsrevisoren SRL/BV |
Diegem, Belgium |
March 24, 2021 |